Home Newsfeeds Pfizer Believes Seagen Could Contribute More Than $10B In Risk-adjusted Revenues In 2030, With Potential Significant Growth Beyond 2030

Pfizer Believes Seagen Could Contribute More Than $10B In Risk-adjusted Revenues In 2030, With Potential Significant Growth Beyond 2030

byBenzinga Newsdesk

March 13, 2023

1 minute read

Global
News

U.S. Embassy In Estonia Says U.S. Will Deploy A High Mobility Artillery Rocket System Platoon And Infantry Company In Estonia In The Coming Weeks

By Benzinga Newsdesk

December 8, 8:17 AM

- Reuters- Reuters

LMT

Cancer Focused Immunocore Leads The Way In TCR Therapeutics, Positioned For Success: Analyst Says

By Vandana Singh

September 13, 2:32 PM

Needham has initiated coverage on Immunocore Holdings Plc (NASDAQ: IMCR) with a Buy rating and

IMCR

Why Nutanix Stock Is Falling After Hours

By Adam Eckert

March 6, 5:21 PM

Nutanix Inc (NASDAQ: NTNX) shares are trading lower in Monday's after-hours session after the company reported preliminary second-quarter results and issued

NTNX

How Is Apple Bullish On iPhone Sales While Overall Industry Is Pessimistic?

By Anusuya Lahiri

August 12, 11:03 AM

Apple Inc (NASDAQ: AAPL) has urged suppliers to build at least as many next-generation iPhones this year as in 2021,

AAPL

Pfizer Believes Seagen Could Contribute More Than $10B In Risk-adjusted Revenues In 2030, With Potential Significant Growth Beyond 2030

Related Posts

U.S. Embassy In Estonia Says U.S. Will Deploy A High Mobility Artillery Rocket System Platoon And Infantry Company In Estonia In The Coming Weeks

Cancer Focused Immunocore Leads The Way In TCR Therapeutics, Positioned For Success: Analyst Says

Why Nutanix Stock Is Falling After Hours

How Is Apple Bullish On iPhone Sales While Overall Industry Is Pessimistic?